Search by Drug Name or NDC
NDC 13845-1202-02 Cycloserine 250 mg/1 Details
Cycloserine 250 mg/1
Cycloserine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Parsolex Gmp Center, Inc.. The primary component is CYCLOSERINE.
Product Information
NDC | 13845-1202 |
---|---|
Product ID | 13845-1202_f2a0bd2c-bd4a-37f0-e053-2995a90a3c85 |
Associated GPIs | 09000030000105 |
GCN Sequence Number | 009319 |
GCN Sequence Number Description | cycloserine CAPSULE 250 MG ORAL |
HIC3 | W1G |
HIC3 Description | ANTITUBERCULAR ANTIBIOTICS |
GCN | 41250 |
HICL Sequence Number | 004038 |
HICL Sequence Number Description | CYCLOSERINE |
Brand/Generic | Generic |
Proprietary Name | Cycloserine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Cycloserine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/1 |
Substance Name | CYCLOSERINE |
Labeler Name | Parsolex Gmp Center, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA060593 |
Listing Certified Through | 2024-12-31 |
Package
NDC 13845-1202-02 (13845120202)
NDC Package Code | 13845-1202-2 |
---|---|
Billing NDC | 13845120202 |
Package | 3 BLISTER PACK in 1 CARTON (13845-1202-2) / 10 CAPSULE in 1 BLISTER PACK |
Marketing Start Date | 2013-09-12 |
NDC Exclude Flag | N |
Pricing Information | N/A |